Motif ID: Foxp1_Foxj2
Z-value: 1.722
Transcription factors associated with Foxp1_Foxj2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Foxj2 | ENSMUSG00000003154.9 | Foxj2 |
Foxp1 | ENSMUSG00000030067.11 | Foxp1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxj2 | mm10_v2_chr6_+_122819888_122819938 | 0.95 | 7.6e-30 | Click! |
Foxp1 | mm10_v2_chr6_-_99266494_99266540 | 0.39 | 2.1e-03 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
5.4 | 16.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
4.6 | 13.8 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
4.1 | 16.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
4.0 | 12.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
4.0 | 11.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
3.7 | 52.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
3.7 | 3.7 | GO:2000834 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
3.4 | 13.5 | GO:0042938 | dipeptide transport(GO:0042938) |
3.3 | 9.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
3.2 | 12.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.0 | 9.1 | GO:1901254 | positive regulation of intracellular transport of viral material(GO:1901254) |
3.0 | 9.1 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
3.0 | 11.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.7 | 8.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
2.4 | 14.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.4 | 7.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.4 | 23.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 11.7 | GO:0071476 | cellular hypotonic response(GO:0071476) |
2.3 | 2.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
2.3 | 29.8 | GO:0070842 | aggresome assembly(GO:0070842) |
2.3 | 6.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
2.2 | 6.5 | GO:1902524 | negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
2.0 | 10.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.0 | 5.9 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
2.0 | 13.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.9 | 5.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.9 | 11.4 | GO:1903056 | melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
1.9 | 5.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.9 | 20.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.8 | 18.3 | GO:0007379 | segment specification(GO:0007379) |
1.8 | 5.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.8 | 7.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.8 | 5.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.8 | 12.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.8 | 17.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
1.8 | 28.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.8 | 7.1 | GO:0007412 | axon target recognition(GO:0007412) |
1.8 | 19.3 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
1.7 | 5.2 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
1.7 | 12.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.7 | 8.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.7 | 11.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.6 | 4.9 | GO:0086069 | desmosome assembly(GO:0002159) bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.6 | 13.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.6 | 6.3 | GO:1990743 | protein sialylation(GO:1990743) |
1.5 | 7.6 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.5 | 11.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.5 | 10.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.4 | 2.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.4 | 9.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.3 | 14.5 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.3 | 7.8 | GO:0019532 | oxalate transport(GO:0019532) |
1.2 | 4.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.2 | 3.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.2 | 9.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.2 | 18.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
1.2 | 1.2 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.2 | 4.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.2 | 2.4 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
1.2 | 3.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
1.2 | 3.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.2 | 15.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.2 | 3.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
1.1 | 21.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
1.1 | 24.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.1 | 6.5 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
1.1 | 7.5 | GO:0002347 | response to tumor cell(GO:0002347) |
1.0 | 5.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.0 | 3.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.0 | 9.2 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.0 | 22.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.0 | 10.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.9 | 3.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.9 | 1.9 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.9 | 3.7 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.9 | 6.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.9 | 4.5 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.9 | 25.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.9 | 8.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.9 | 2.6 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.8 | 3.4 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.8 | 8.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 7.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.8 | 14.8 | GO:0001553 | luteinization(GO:0001553) |
0.8 | 3.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.8 | 8.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.8 | 7.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.8 | 7.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.8 | 8.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 0.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.8 | 3.2 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.8 | 2.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.8 | 16.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.8 | 4.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 3.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.7 | 3.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.7 | 3.7 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.7 | 1.5 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.7 | 2.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.7 | 2.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.7 | 5.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 11.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 2.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.7 | 2.8 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 9.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 14.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.7 | 6.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.7 | 2.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.7 | 8.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.7 | 2.0 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.7 | 3.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.7 | 20.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.6 | 2.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.6 | 9.6 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.6 | 6.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.6 | 3.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.6 | 25.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 22.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.6 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 5.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.6 | 1.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.6 | 1.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.6 | 1.7 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.6 | 3.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 1.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.6 | 5.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.6 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 2.8 | GO:0032911 | nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 3.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 3.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 1.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.5 | 2.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 8.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.5 | 6.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 7.3 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.5 | 4.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 2.5 | GO:0021856 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) facioacoustic ganglion development(GO:1903375) positive regulation of male gonad development(GO:2000020) |
0.5 | 1.5 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.5 | 4.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 1.5 | GO:0044849 | estrous cycle(GO:0044849) |
0.5 | 8.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 3.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 1.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 3.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 18.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.5 | 2.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.9 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.5 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 5.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 1.4 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 6.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.5 | 0.9 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.5 | 2.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 12.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 7.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 2.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 2.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 2.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 2.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 3.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.4 | 1.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.4 | 5.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 8.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.4 | 5.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 2.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 3.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.4 | 8.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 5.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.1 | GO:1902219 | maintenance of blood-brain barrier(GO:0035633) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 4.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 3.4 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.4 | 2.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 4.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 2.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.4 | 3.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 13.7 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.4 | 0.7 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.4 | 2.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 1.1 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.4 | 1.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 8.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 1.0 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.3 | 1.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.3 | 2.0 | GO:0002931 | response to ischemia(GO:0002931) |
0.3 | 5.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.0 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.3 | 1.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 5.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 2.0 | GO:0046103 | ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
0.3 | 4.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 1.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 6.8 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.3 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 1.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 4.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 4.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 1.9 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 1.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.3 | 3.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 24.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.3 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.3 | 3.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 3.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 2.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 2.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 4.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.3 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 3.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 1.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 6.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 3.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.3 | 4.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 4.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 4.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 1.8 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.3 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 4.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.0 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 6.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 2.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 2.7 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.2 | 1.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 1.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 2.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 17.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.9 | GO:0032095 | regulation of response to food(GO:0032095) |
0.2 | 4.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.9 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 0.4 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.2 | 6.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 1.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 2.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 4.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 4.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 1.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 4.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 1.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 1.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 1.6 | GO:0006265 | resolution of meiotic recombination intermediates(GO:0000712) DNA topological change(GO:0006265) |
0.2 | 2.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 6.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 1.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 2.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.5 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 13.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 3.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 3.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 1.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 3.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 6.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.5 | GO:0036230 | granulocyte activation(GO:0036230) |
0.2 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 4.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 1.5 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.1 | 1.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 1.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.7 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 1.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 1.7 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 1.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 2.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 2.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 2.4 | GO:0014741 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 8.9 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 8.8 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.4 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) rRNA 3'-end processing(GO:0031125) |
0.1 | 1.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.6 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 2.5 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 4.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.8 | GO:0071941 | nitrate metabolic process(GO:0042126) nitrogen cycle metabolic process(GO:0071941) |
0.1 | 2.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 2.8 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.7 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 1.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 2.4 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.6 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 6.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 1.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 1.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 1.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 3.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 2.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 5.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 2.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 1.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 3.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.4 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 1.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 1.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 2.8 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.7 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 10.1 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 1.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.7 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
0.1 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 1.7 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) mRNA destabilization(GO:0061157) |
0.1 | 2.8 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.8 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 6.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 2.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.8 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 1.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 2.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 5.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 2.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 1.0 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 3.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 1.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 1.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.0 | 1.2 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) negative regulation of interferon-beta production(GO:0032688) |
0.0 | 1.6 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 1.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 1.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.9 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 18.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.0 | 9.1 | GO:0042025 | viral replication complex(GO:0019034) host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
2.5 | 27.7 | GO:0031931 | TORC1 complex(GO:0031931) |
2.4 | 9.6 | GO:0044307 | dendritic branch(GO:0044307) |
2.3 | 7.0 | GO:0014802 | terminal cisterna(GO:0014802) |
2.0 | 9.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.9 | 5.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.6 | 4.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.6 | 15.9 | GO:0044327 | dendritic spine head(GO:0044327) |
1.4 | 5.6 | GO:0031673 | H zone(GO:0031673) |
1.4 | 7.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.3 | 17.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
1.3 | 3.8 | GO:0043512 | inhibin A complex(GO:0043512) |
1.2 | 4.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.2 | 3.7 | GO:0044754 | amphisome(GO:0044753) autolysosome(GO:0044754) |
1.1 | 10.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
1.1 | 16.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 15.0 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 3.9 | GO:0005712 | chiasma(GO:0005712) |
0.9 | 8.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 5.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 28.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 11.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 2.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 2.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.7 | 7.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 5.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 8.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 14.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 7.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.6 | 6.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 11.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.6 | 20.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 5.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 9.2 | GO:0031430 | M band(GO:0031430) |
0.5 | 9.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 2.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 5.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 5.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 3.2 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 2.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 3.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 5.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 4.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 14.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 1.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 2.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.4 | 1.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 11.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 3.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 1.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 2.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 7.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 4.1 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 3.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 4.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 16.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 2.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 15.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 6.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 3.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 7.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 4.3 | GO:0031672 | A band(GO:0031672) |
0.3 | 20.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 2.2 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 1.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 4.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 16.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 2.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 4.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 22.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 6.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 5.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 4.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 3.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 4.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 82.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 10.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.7 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 4.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 2.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 5.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 9.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 2.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 6.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 4.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 2.6 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.2 | 10.4 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 1.5 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 0.9 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 7.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 49.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 7.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 5.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 15.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 11.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 5.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 4.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 2.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 24.2 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.5 | GO:0032281 | ionotropic glutamate receptor complex(GO:0008328) AMPA glutamate receptor complex(GO:0032281) neurotransmitter receptor complex(GO:0098878) |
0.1 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.2 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 2.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 22.4 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 4.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 7.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 16.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 5.9 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 2.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 7.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 5.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 2.2 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 10.4 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 1.3 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 1.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 4.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 2.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 19.6 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
5.6 | 22.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
3.9 | 11.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
3.3 | 19.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.0 | 21.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
3.0 | 11.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.9 | 8.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
2.7 | 13.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
2.7 | 16.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.4 | 7.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.3 | 9.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
2.1 | 10.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
2.1 | 8.4 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
2.0 | 8.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
2.0 | 5.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.9 | 11.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.8 | 9.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.8 | 10.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.7 | 6.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.7 | 11.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.7 | 16.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.6 | 4.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.6 | 4.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.6 | 7.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.5 | 7.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.5 | 5.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 7.2 | GO:0071253 | connexin binding(GO:0071253) |
1.4 | 4.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
1.4 | 8.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.4 | 13.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.3 | 3.9 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
1.3 | 30.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.3 | 10.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.3 | 6.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.3 | 5.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.2 | 10.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.2 | 6.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.2 | 3.7 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.2 | 4.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.2 | 3.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.1 | 4.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.1 | 6.8 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 3.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.1 | 5.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
1.0 | 4.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.0 | 5.2 | GO:0097001 | ceramide binding(GO:0097001) |
1.0 | 19.6 | GO:0042287 | MHC protein binding(GO:0042287) |
1.0 | 5.9 | GO:0015265 | urea channel activity(GO:0015265) |
1.0 | 3.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.9 | 8.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.9 | 8.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.9 | 12.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 3.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 3.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.8 | 3.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 2.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) |
0.8 | 7.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.8 | 3.2 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.8 | 7.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 2.3 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.7 | 22.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 4.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 2.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.7 | 7.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.7 | 9.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 2.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 3.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.7 | 4.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 3.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 5.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 13.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.7 | 11.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 3.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 3.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 3.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 1.8 | GO:0019966 | C-X-C chemokine binding(GO:0019958) interleukin-1 binding(GO:0019966) tumor necrosis factor binding(GO:0043120) |
0.6 | 2.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 21.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 6.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 2.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 5.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 3.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 5.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 12.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 1.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 9.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.5 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 1.9 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.5 | 2.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 2.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 5.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 9.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 4.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 2.4 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 2.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 3.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.4 | 3.6 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.4 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 2.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 1.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 8.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 3.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 4.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 2.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 3.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 4.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.3 | 13.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 1.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 4.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 3.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 4.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 4.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 6.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 40.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 2.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 11.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 2.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 9.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 6.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 3.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 2.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 5.1 | GO:0035380 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.2 | 2.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 4.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 1.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 5.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 4.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.6 | GO:0070404 | 6,7-dihydropteridine reductase activity(GO:0004155) NADH binding(GO:0070404) |
0.2 | 3.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 2.8 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 7.0 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.4 | GO:0032184 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) SUMO polymer binding(GO:0032184) |
0.2 | 2.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 5.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 2.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 4.4 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 3.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 4.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 16.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 3.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 4.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.8 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 2.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 3.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 2.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 2.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 2.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 2.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 5.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 16.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 8.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 2.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 1.7 | GO:0070636 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 6.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 5.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 8.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.3 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 2.2 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.1 | 0.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 3.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 3.5 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 1.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 4.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 3.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 5.3 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.5 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 6.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 2.1 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 9.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 5.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 9.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 20.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 4.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.5 | GO:0008758 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 1.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 1.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 2.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 1.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0015189 | L-ornithine transmembrane transporter activity(GO:0000064) arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 2.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |